Ventio

Ventio is a French medical-imaging company headquartered in Marseille. It develops technology around magnetic susceptibility and magnetic resonance imaging (MRI), with the goal of revealing tissue contrasts that conventional imaging cannot show. Its flagship innovation is BriSE (Break-through in susceptibility enhancement), a method that measures the magnetization of tissues within an MRI magnetic field, analogous to how a compass aligns with the Earth's magnetic field. According to the company, this approach produces resolved images with exceptional sensitivity to help guide diagnosis and better monitor neurological diseases. Ventio frames its work around the role of iron in biology. Iron is described as the 'battery of life,' supporting oxygen transport, cellular respiration and energy production in mammals. In the brain, much of the energy produced by cells supports neuronal activity essential to cognitive functions, and this activity depends on iron for neurotransmitter production, axonal membrane formation and neuron function. Iron is also involved in the death of brain cells. Within cells, iron is stored as magnetic nano-crystals inside ferritin, a protein found in all living species; iron-loaded ferritin accumulates in cells and is degraded in the lysosome when free iron is needed. BriSE measures this magnetism, providing a window into iron-related tissue properties. The company positions its technology as a disruptive innovation intended to be made available to patients, with a mission to improve diagnosis and monitoring of neurological disease. Its public communication emphasizes both the scientific basis of magnetic susceptibility imaging and the clinical potential of visualizing iron in tissue. Ventio operates from Marseille and presents itself primarily through its official website, ventio.net, where it describes BriSE and the biology of iron in the brain. Beyond these public materials, detailed corporate information such as founding year, founders, ownership and funding is not established in the available evidence.

Ventio is a company based in Marseille, France, active in medical imaging. Public evidence identifies it as a company in Marseille and describes its technology focus, but does not provide a founding date, founders, or a detailed corporate timeline. What is documented is its technological proposition: BriSE, a method for measuring magnetic susceptibility in MRI. The company explains that magnetic susceptibility indicates how susceptible matter is to becoming magnetized in a magnetic field, and that BriSE allows measurement of tissue magnetization within an MRI's magnetic field, analogous to a compass orienting in the Earth's magnetic field. Ventio states that this innovation yields resolved images with exceptional sensitivity to guide diagnosis and better monitor neurological diseases, and that its mission is to make this breakthrough innovation available to patients. A central theme of Ventio's public communication is the biology of iron. The company describes iron as the 'battery of life,' noting its roles in oxygen transport, cellular respiration and energy production in mammals. In the brain, it explains, much of the energy produced by cells serves neuronal activity essential to cognitive functions, and this activity depends on iron for neurotransmitter production, axonal membrane formation and proper neuron function. Iron is also implicated in the death of brain cells. Inside cells, iron is stored as magnetic nano-crystals within ferritin, a protein found in all living species; iron-loaded ferritin accumulates and is degraded in the lysosome when the cell needs free iron. BriSE measures this magnetism, connecting the physics of magnetic susceptibility to the biochemistry of iron storage in tissue. The company also references 'BIaaS' in the context of iron as a key element of life, suggesting a service or platform related to iron imaging, though the evidence does not elaborate on its scope. Ventio presents itself through its official website, ventio.net, which serves as the primary public source about its mission and technology. No information about ownership, funding, partnerships, regulatory approvals, or commercial deployments is available in the supplied evidence, so the corporate history beyond its technological positioning remains undocumented here.

Developer of disruptive magnetic-susceptibility MRI technology aimed at revealing invisible tissue contrasts and improving diagnosis and monitoring of neurological diseases.

• BriSE

  Break-through in susceptibility enhancement: a magnetic-susceptibility MRI technology that measures tissue magnetization in an MRI magnetic field to reveal invisible tissue contrasts and support diagnosis and monitoring of neurological diseases.

• BIaaS

  Referenced by Ventio in the context of iron as a key element of life; appears to be a service or offering related to iron imaging, though details are not provided in the evidence.

1. 1Home - Susceptibilité magnétique et imagerie médicale | Ventioventio.net
2. 2Ventio (France) - Wikidatawikidata.org